Evaluation of the pre- and postoperative visual outcomes of phacoemulsification in patients with uveitis-associated cataract.

Evaluation of the pre- and postoperative visual outcomes of phacoemulsification in patients with uveitis-associated cataract. - Evaluation of the pre- and postoperative visual outcomes of phacoemulsification in patients with uveitis-associated cataract.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041141

Enrollment

Registered

2020-07-17

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: /The patients aged older than 50 years who were required cataract surgery with IOL implantation were included. Before surgery, quiescence of intraocular inflammation for more than 3 months with absence of systemic immunosuppressive therapy was a pre-requisite for eligibility for the surgery in patients with uveitis. /Patients without /Patients who had not undergone intraocular surgery.

Exclusion criteria

Exclusion criteria: /The patients with any previous ocular surgery in the eligible eye, preoperative trauma, pre-existing macular pathologies, vitreous hemorrhage, diabetes mellitus, rhegmatogenous retinal detachment, ocular surface disorders, glaucoma uncontrolled with medical treatment, and optic atrophy which were likely to affect surgical outcome, were excluded from the study. /Patients with systemic immunsuppressive therapy. /Patients who had undergone intraocular surgery. /Patients who were judged as no application by doctor.

Design outcomes

Primary

Measure	Time frame
Intraocular inflammation measured by laser flare cell meter	—

Secondary

Measure	Time frame
Clinical findings	—

Countries

Japan

Contacts

Public ContactAtsunobu Takeda

Graduate School of Medical Sciences, Kyushu University Department of Ophthalmology

atakeda@med.kyushu-u.ac.jp092-642-5648

Outcome results